AZD1480

For research use only.

Catalog No.S2162

90 publications

AZD1480 Chemical Structure

CAS No. 935666-88-9

AZD1480 is a novel ATP-competitive JAK2 inhibitor with IC50 of 0.26 nM in a cell-free assay, selectivity against JAK3 and Tyk2, and to a smaller extent against JAK1. Phase 1.

Selleck's AZD1480 has been cited by 90 publications

Purity & Quality Control

Choose Selective JAK Inhibitors

Biological Activity

Description AZD1480 is a novel ATP-competitive JAK2 inhibitor with IC50 of 0.26 nM in a cell-free assay, selectivity against JAK3 and Tyk2, and to a smaller extent against JAK1. Phase 1.
Targets
JAK2 [1]
(Cell-free assay)
0.26 nM
In vitro

5μM AZD1480 induces G2/M arrest and cell death by inhibiting Aurora kinases. [1] AZD1480 is a potent JAK2 inhibitor that can suppress growth, survival, as well as FGFR3 and STAT3 signaling and downstream targets including Cyclin D2 in human multiple myeloma cells. At low micromolar concentrations, AZD1480 blocks cell proliferation and induces apoptosis of myeloma cell lines. [2]AZD1480 effectively blocks constitutive and stimulus-induced JAK1, JAK2, and STAT-3 phosphorylation in both human and murine glioma cells, and leads to a decrease in cell proliferation and induction of apoptosis. [3]AZD1480 is a potent, competitive small-molecule inhibitor of JAK1/2 kinase, and that it is capable of inhibiting STAT3 phosphorylation and tumor growth in a STAT3-dependent manner. AZD1480 inhibits tumor angiogenesis and metastasis in part by affecting the tumor microenvironment. [4]

Cell Data
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID
SW620 NHS3RWJHfW6ldHnvckBCe3OjeR?= NX;EdmFoPSEQvF2= M13MPFQ5KGh? NILP[WVFVVOR MofWZoxw[2u|IFrBT|IwW1SDVEOgd4lodmGuaX7n M2KwXFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ3OUW0PVc1Lz5{NUm1OFk4PDxxYU6=
LoVo  NGHoN45HfW6ldHnvckBCe3OjeR?= M2W4cVUh|ryP Mn;ZOFghcA>? M4LsXmROW09? NIPsU29jdG:la4OgTmFMOi:VVFHUN{B{cWewYXzpcoc> NGP3S5I9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NUm1OFk4PCd-MkW5OVQ6PzR:L3G+
HN5 MWHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NF3E[og4OiCq M{ThRWVEPTB;Mz64NUDDuSBzLkm5JO69VQ>? NGTZNIk9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NUixNFAyOCd-MkW4NVAxOTB:L3G+
Cal33 MYrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M4r0elczKGh? NH;RWWpGSzVyPUOuN|chyrFiMD63OUDPxE1? MUW8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPThzMECxNEc,OjV6MUCwNVA9N2F-
UM-22B NYfYeJQzT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MUC3NkBp NIXaPJlGSzVyPUKuOlYhyrFiMD6yOEDPxE1? NHzObnk9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NUixNFAyOCd-MkW4NVAxOTB:L3G+
686LN M3nVVWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NHzCeHM4OiCq MVzFR|UxRTJwMEWgxtEhOS5|MzFOwG0> NVPr[mhORGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkW4NVAxOTBpPkK1PFExODFyPD;hQi=>
UM SCC-1 MUHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MV23NkBp NVfVWo8zTUN3ME2xMlY4KMLzIECuOFIh|ryP NFHF[WE9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NUixNFAyOCd-MkW4NVAxOTB:L3G+
UM-22A MmTaS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NUTJeo1OPzJiaB?= NX3RNIE{TUN3ME2xMlMzKMLzIECuN|kh|ryP MVK8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPThzMECxNEc,OjV6MUCwNVA9N2F-
OSC19 M2PNNWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 Ml\HO|IhcA>? NVLGdWY2TUN3ME2xMlI3KMLzIECuNlAh|ryP Mlu3QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjV6MUCwNVAoRjJ3OEGwNFExRC:jPh?=
PCI-52 MnjQS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MVK3NkBp MUjFR|UxRTFwMECgxtEhOC5yOTFOwG0> NYS4dmtJRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkW4NVAxOTBpPkK1PFExODFyPD;hQi=>
PCI-15B MmLOS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NXrOUoxRPzJiaB?= NX3ZbWdUTUN3ME2wMlk6KMLzIEGuO|Qh|ryP NUTKN3J1RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkW4NVAxOTBpPkK1PFExODFyPD;hQi=>
UMSCC-1 MV7GeY5kfGmxbjDBd5NigQ>? NGHoZWoxNjByMEWtNU43KM7:TR?= MlrkNlQhcA>? NGLsRXpi[nKxZ3H0[ZMhUUxvNvMAl4lv\HWlZXSgeZAuemWpdXzheIlwdiCxZjDwV3RCXDOWeYK3NFXDqGmwIHGg[I9{\S2mZYDlcoRmdnRibXHucoVz Mn3RQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjV6MUCwNVAoRjJ3OEGwNFExRC:jPh?=
Cal33 MX\GeY5kfGmxbjDBd5NigQ>? MUKwMlAxODVvMz64JO69VQ>? MlnyNlQhcA>? Mmj2ZYJzd2ejdHXzJGlNNTckgKPpcoR2[2WmIIXwMZJm\3WuYYTpc44hd2ZicGPURXQ{XHm{N{C1xsBqdiCjIHTvd4Uu\GWyZX7k[Y51KG2jbn7ldi=> MUG8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPThzMECxNEc,OjV6MUCwNVA9N2F-
HH5 MXPGeY5kfGmxbjDBd5NigQ>? MoK1NE4xODB3LUOuPEDPxE1? M{DGeFI1KGh? M4jBSYFjem:pYYTld{BKVC144pETbY5lfWOnZDD1dE1z\We3bHH0bY9vKG:oIIDTWGFVO1S7ckewOeKhcW5iYTDkc5NmNWSncHXu[IVvfCCvYX7u[ZI> MljhQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjV6MUCwNVAoRjJ3OEGwNFExRC:jPh?=
UM-22A MUHGeY5kfGmxbjDBd5NigQ>? MYGwMlAxODVvMT62JO69VQ>? NEDDXIMzPCCq NHOzU4hi[nKxZ3H0[ZMhUUxvNvMAl4lv\HWlZXSgeZAuemWpdXzheIlwdiCxZjDwV3RCXDOWeYK3NFXDqGmwIHGg[I9{\S2mZYDlcoRmdnRibXHucoVz NX7m[np{RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkW4NVAxOTBpPkK1PFExODFyPD;hQi=>
A1847 NFnCdY9HfW6ldHnvckBCe3OjeR?= NHfmWXAxNjB3LUGwJO69VQ>? M2nKOlI1KGh? NXW1SZBnTE2VT9Mg NGDkc5Bz\WS3Y3XzJJBpd3OyaH;yfYxifGWmIGPURXQ{KGyndnXsdy=> MXm8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPTZ2NkCxOUc,OjV4NE[wNVU9N2F-
OVCAR-5 M2LMe2Z2dmO2aX;uJGF{e2G7 NWDLNXhTOC5yNT2xNEDPxE1? NIXm[4EzPCCq M3rTdGROW00EoB?= M2PDTJJm\HWlZYOgdIhwe3Cqb4L5cIF1\WRiU2TBWFMhdGW4ZXzz MnjxQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjV4NE[wNVUoRjJ3NkS2NFE2RC:jPh?=
OVCAR-8 NEHGb3FHfW6ldHnvckBCe3OjeR?= M{jwXlAvODVvMUCg{txO M3:zNVI1KGh? NYn5[Gd2TE2VT9Mg M3fjbJJm\HWlZYOgdIhwe3Cqb4L5cIF1\WRiU2TBWFMhdGW4ZXzz MkPDQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjV4NE[wNVUoRjJ3NkS2NFE2RC:jPh?=
MOVCAR-5447 M{fSdGZ2dmO2aX;uJGF{e2G7 MkH1NE4xPS1zMDFOwG0> NX\YeWpsOjRiaB?= MoDtSG1UV8Li MXry[YR2[2W|IIDoc5NxcG:{eXzheIVlKFOWQWSzJIxmfmWucx?= MYO8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPTZ2NkCxOUc,OjV4NE[wNVU9N2F-
MOVCAR-5009 MV\GeY5kfGmxbjDBd5NigQ>? MWOwMlA2NTFyIN88US=> NEXqbnYzPCCq NHHkWWJFVVORwrC= M1v5XJJm\HWlZYOgdIhwe3Cqb4L5cIF1\WRiU2TBWFMhdGW4ZXzz M3fTc|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ3NkS2NFE2Lz5{NU[0OlAyPTxxYU6=
A1847 NHvaS5NE\WyuIG\pZYJqdGm2eTDBd5NigQ>? MkXHNE4xPS1zMDFOwG0> NXric4N2PzJiaB?= Mlz0SG1UVw>? MnKzdoVlfWOnczDj[YxtKH[rYXLpcIl1gSCjdDD0bIUh[2:wY3XycpRz[XSrb36gc4YhPSEQvF2= M1;uXVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ3NkS2NFE2Lz5{NU[0OlAyPTxxYU6=
OVCAR-5 NHH2WVRE\WyuIG\pZYJqdGm2eTDBd5NigQ>? NVPKd3dLOC5yNT2xNEDPxE1? Mnn2O|IhcA>? M1TLNGROW09? NVPRRnl4emWmdXPld{Bk\WyuII\pZYJqdGm2eTDheEB1cGViY3;uZ4VzdnS{YYTpc44hd2ZiNTFOwG0> MnjwQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjV4NE[wNVUoRjJ3NkS2NFE2RC:jPh?=
OVCAR-8  NHTTWJFE\WyuIG\pZYJqdGm2eTDBd5NigQ>? Mo\INE4xPS1zMDFOwG0> NXfVZmxLPzJiaB?= NY[3OGllTE2VTx?= MYLy[YR2[2W|IHPlcIwhfmmjYnnsbZR6KGG2IITo[UBkd26lZYLueJJifGmxbjDv[kA2KM7:TR?= NFTreJU9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NU[0OlAyPSd-MkW2OFYxOTV:L3G+
OVCAR-5  M13Le2Fxd3C2b4Ppd{BCe3OjeR?= NUTLXWxyOC53L{GvOUDPxE1? M2T1UFQ5KGh? MXLEUXNQ MlfNbY5lfWOnczDzbYdvcW[rY3HueEBieG:ydH;zbZMh[XRiaHnnbEBkd26lZYLueJJifGmxbh?= M1XpdFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ3NkS2NFE2Lz5{NU[0OlAyPTxxYU6=
OVCAR-8  NWG4OWhzSXCxcITvd4l{KEG|c3H5 M4DxcFAvPS9zL{Wg{txO NVnqWnJbPDhiaB?= M3S4VWROW09? M3rnN4lv\HWlZYOgd4lodmmoaXPhcpQh[XCxcITvd4l{KGG2IHjp[4gh[2:wY3XycpRz[XSrb36= MYi8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPTZ2NkCxOUc,OjV4NE[wNVU9N2F-
AKRSL M3vteGNmdGxiVnnhZoltcXS7IFHzd4F6 M4ntclczKGh? M1HDXGlEPTExvK6xNEDPxE1? MnjKQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjV3MES2N|UoRjJ3NUC0OlM2RC:jPh?=
PALJDL NUX1VW0{S2WubDDWbYFjcWyrdImgRZN{[Xl? NUmxXHh{PzJiaB?= Mnv0TWM2OD1{LkSg{txO NYXIdm9iRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkW1NFQ3OzVpPkK1OVA1PjN3PD;hQi=>
MO4 M1;BUGZ2dmO2aX;uJGF{e2G7 MWOwMlUwOS93IN88US=> M3m4U|YhcA>? MYLpcohq[mm2czDQMXNVSVR|IHX4dJJme3Orb39CpC=> M4jnTlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ3MUS5OVM2Lz5{NUG0PVU{PTxxYU6=
DU145  MUfGeY5kfGmxbjDBd5NigQ>? MlvHNE0zODBibl2= M3nae|EhcMLi MWLzeZBxemW|c3XzJGlNNTZvYXP0bZZifGWmIGP0ZZQ{KGGwZDDFVmsyNzJic3nncoFtcW6p MV:8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPDV5N{m0Nkc,OjR3N{e5OFI9N2F-
DU145  M4jZZ2Z2dmO2aX;uJGF{e2G7 MmLHPFAxKG6P NYXYbVl{PzJiaB?= MV7zeZBxemW|c3XzJGlNNTZvaX7keYNm\CCvaXfyZZRwenl? NXvZeGY6RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkS1O|c6PDJpPkK0OVc4QTR{PD;hQi=>
CWR22Rv1 MmTLSpVv[3Srb36gRZN{[Xl? MkDpPFAxKG6P MYi3NkBp MlTud5VxeHKnc4Pld{BKVC14LXnu[JVk\WRibXnndoF1d3K7 MojXQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjR3N{e5OFIoRjJ2NUe3PVQzRC:jPh?=
N592 NFmzO4RIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MXHJR|UxRTBwOESg{txO MY[8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPDF3OEewNUc,OjRzNUi3NFE9N2F-
H82 MVPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MmfKTWM2OD1zLkO3JO69VQ>? MWG8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPDF3OEewNUc,OjRzNUi3NFE9N2F-
GLC4 Mly4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MmTCTWM2OD1zLke5JO69VQ>? Ml7xQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjRzNUi3NFEoRjJ2MUW4O|AyRC:jPh?=
H526 MXrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NIjIbJhKSzVyPUOuNFgh|ryP MYC8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPDF3OEewNUc,OjRzNUi3NFE9N2F-
H1173 M4DJZWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M4LCeGlEPTB;Mj6zPUDPxE1? M1HENlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ2MUW4O|AyLz5{NEG1PFcxOTxxYU6=
DMS114 M2\5UWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MX3JR|UxRTBwN{Og{txO NHf2b5Y9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NEG1PFcxOSd-MkSxOVg4ODF:L3G+
NCI-N592 NH\SXXNHfW6ldHnvckBCe3OjeR?= NVHvPGtZOC5|L{GvN{DPxE1? NGHkZoIzPCCq MmnCbY5lfWOnczDHNk9OKGOnbHygZ5lkdGViYYLy[ZN1 M2XTWFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ2MUW4O|AyLz5{NEG1PFcxOTxxYU6=
GLC4 MlfmSpVv[3Srb36gRZN{[Xl? MnHnNE4{NzFxMzFOwG0> Ml\UNlQhcA>? NWDNV4U3cW6mdXPld{BIOi:PIHPlcIwh[3mlbHWgZZJz\XO2 MUm8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPDF3OEewNUc,OjRzNUi3NFE9N2F-
NCI-H82 NF3CRYlHfW6ldHnvckBCe3OjeR?= NWHwepVUOC5|L{GvN{DPxE1? MV2yOEBp NIrNWW1qdmS3Y3XzJGczN01iY3XscEBkgWOuZTDhdpJme3R? MUS8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPDF3OEewNUc,OjRzNUi3NFE9N2F-
NCI-N592 MVzBdI9xfG:|aYOgRZN{[Xl? MXmwMlMwOS9|IN88US=> NVy2XWZGPDhiaB?= M1LjV4lv[3KnYYPld{B1cGVibHX2[Ywhd2ZiY3zlZZZm\C2FYYPwZZNmKDN? M1rmSVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ2MUW4O|AyLz5{NEG1PFcxOTxxYU6=
GLC4 NHraOHFCeG:ydH;zbZMhSXO|YYm= M{PUflAvOy9zL{Og{txO M4jwNlQ5KGh? NF;vZYJqdmO{ZXHz[ZMhfGinIHzleoVtKG:oIHPs[YF3\WRvQ3HzdIF{\SB| MXG8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPDF3OEewNUc,OjRzNUi3NFE9N2F-
NCI-H82 NVnSSpJLSXCxcITvd4l{KEG|c3H5 M1XPUVAvOy9zL{Og{txO MkG1OFghcA>? Mmn3bY5kemWjc3XzJJRp\SCuZY\lcEBw\iClbHXheoVlNUOjc4Dhd4UhOw>? MWS8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPDF3OEewNUc,OjRzNUi3NFE9N2F-
CWR22Rv1  NEfEUGpCeG:ydH;zbZMhSXO|YYm= MXTJR|UxRTBwNEiyJO69VQ>? NEHPW|Q9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{M{m0NlA6PSd-MkO5OFIxQTV:L3G+
CWR22Pc M1vwTmFxd3C2b4Ppd{BCe3OjeR?= MonXTWM2OD1yLkSzPEDPxE1? MmTtQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjN7NEKwPVUoRjJ|OUSyNFk2RC:jPh?=
PC-3 Mkf3RZBweHSxc3nzJGF{e2G7 NH7MSodKSzVyPUGuO|U2KM7:TR?= MnjIQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjN7NEKwPVUoRjJ|OUSyNFk2RC:jPh?=
DU145 NVT1UHRtSXCxcITvd4l{KEG|c3H5 Mkj3TWM2OD1|LkWxO{DPxE1? NHjiVmI9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{M{m0NlA6PSd-MkO5OFIxQTV:L3G+
RC165N NWnzNGs3SXCxcITvd4l{KEG|c3H5 M{\ie2lEPTB;Mj6wPFMh|ryP NXezfJBnRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkO5OFIxQTVpPkKzPVQzODl3PD;hQi=>
ARPE19 Mn76S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? Mmr4SG1UVw>? NHn1fHFKSzVyPUK0MlM5KM7:TR?= MmHnQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjN3M{G5NlEoRjJ|NUOxPVIyRC:jPh?=
HEK293 MVrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MV7EUXNQ MXPJR|UxRThwNkeg{txO NW\DemFzRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkO1N|E6OjFpPkKzOVMyQTJzPD;hQi=>
KCNR NEn0eW9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MnfsSG1UVw>? NEDZbJRKSzVyPUCuOFYh|ryP MXG8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOzV|MUmyNUc,OjN3M{G5NlE9N2F-
SY5Y NYjJbFhGT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MY\EUXNQ NEHxPINKSzVyPUCuN|Yh|ryP MmjYQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjN3M{G5NlEoRjJ|NUOxPVIyRC:jPh?=
BE2 NXvIOJl6T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NV\iWmE6TE2VTx?= MmTFTWM2OD1yLkexJO69VQ>? MXq8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOzV|MUmyNUc,OjN3M{G5NlE9N2F-
AS MleyS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NGGwO|VFVVOR NV\qZZBrUUN3ME2xMlU{KM7:TR?= MVm8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOzV|MUmyNUc,OjN3M{G5NlE9N2F-
NGP NUjpS456T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NUTx[Gs6TE2VTx?= NH;aWnNKSzVyPUCuOVYh|ryP MWC8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOzV|MUmyNUc,OjN3M{G5NlE9N2F-
IMR32 M1LyNWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NV;Z[JVTTE2VTx?= NFPlR5hKSzVyPUCuOlYh|ryP M4C4OFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ|NUOxPVIyLz5{M{WzNVkzOTxxYU6=
LAN5 M1;B[mdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MWfEUXNQ M2XV[2lEPTB;MT6wOEDPxE1? MXe8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOzV|MUmyNUc,OjN3M{G5NlE9N2F-
RH18 Mn3uS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MnjESG1UVw>? M1Swb2lEPTB;MT60NkDPxE1? MnPGQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjN3M{G5NlEoRjJ|NUOxPVIyRC:jPh?=
RH30 MnjJS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NWXXc2tCTE2VTx?= Mlf4TWM2OD1zLkK1JO69VQ>? MlnLQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjN3M{G5NlEoRjJ|NUOxPVIyRC:jPh?=
RH17 M1nzO2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NIjlZpZFVVOR MmCxTWM2OD1{LkWxJO69VQ>? NYC0W4NIRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkO1N|E6OjFpPkKzOVMyQTJzPD;hQi=>
RH28 NYnB[lNST3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NXHITFQyTE2VTx?= NH2wWoZKSzVyPUSuNlgh|ryP Mn7PQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjN3M{G5NlEoRjJ|NUOxPVIyRC:jPh?=
RH36 M4fpbmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NH;QOG9FVVOR NHnkTZRKSzVyPUWuN|ch|ryP NUDjTHlFRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkO1N|E6OjFpPkKzOVMyQTJzPD;hQi=>
RH41 MnzkS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NIXR[2xFVVOR NYfW[I1XUUN3ME2wMlQ5KM7:TR?= NVTMXG5xRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkO1N|E6OjFpPkKzOVMyQTJzPD;hQi=>
RD MmHvS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NXXIUlZvTE2VTx?= NV7vSolRUUN3ME20MlMzKM7:TR?= M1jpXFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ|NUOxPVIyLz5{M{WzNVkzOTxxYU6=
TC32 MnvyS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NUKxNWk4TE2VTx?= NF74R5pKSzVyPUOuPFUh|ryP Mn\BQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjN3M{G5NlEoRjJ|NUOxPVIyRC:jPh?=
TC71 NUDhboJHT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M3jGXmROW09? MoTnTWM2OD12LkOzJO69VQ>? NIX1SFU9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{M{WzNVkzOSd-MkO1N|E6OjF:L3G+
KCNR NXrxRZN7SXCxcITvd4l{KEG|c3H5 NWTnSFJDOC53L{GuNE8zNjVizszN NF7tR2QzPCCq MX7EUXNQ NIi5WndqdmS3Y3XzJIFvKGmwY4LlZZNmKGmwIHPhd5Bie2ViMz:3JIFkfGm4aYT5 NWXpSGNkRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkO1N|E6OjFpPkKzOVMyQTJzPD;hQi=>
SY5Y M{LlcWFxd3C2b4Ppd{BCe3OjeR?= NH\ZWJUxNjVxMT6wM|IvPSEQvF2= MXKyOEBp MX3EUXNQ NUPBW5M3cW6mdXPld{BidiCrbnPy[YF{\SCrbjDjZZNx[XOnIEOvO{Bi[3Srdnn0fS=> MVO8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOzV|MUmyNUc,OjN3M{G5NlE9N2F-
Rh18 M{KyTGFxd3C2b4Ppd{BCe3OjeR?= MXqwMlUwOS5yL{KuOUDPxE1? NVvEPZNLOjRiaB?= Mk\oSG1UVw>? MlfzbY5lfWOnczDhckBqdmO{ZXHz[UBqdiClYYPwZZNmKDNxNzDhZ5Rqfmm2eR?= MXG8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOzV|MUmyNUc,OjN3M{G5NlE9N2F-
TC32 M2W1NWFxd3C2b4Ppd{BCe3OjeR?= MoL5NE42NzFwMD:yMlUh|ryP MXmyOEBp M4ewUGROW09? M37qWolv\HWlZYOgZY4hcW6lcnXhd4UhcW5iY3HzdIF{\SB|L{egZYN1cX[rdIm= NVTJbZpNRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkO1N|E6OjFpPkKzOVMyQTJzPD;hQi=>
KCNR MWrGeY5kfGmxbjDBd5NigQ>? NITs[JkxNjVxMT6wM|IvPS93IN88US=> NG\LNWszPCCq MXXEUXNQ M1XKPYlvcGmkaYTzJIJwfGhiZX7kc4dmdm:3czDjc45{fGm2dYTpeoUh[W6mIFnMMVYucW6mdXPl[EBUXEGWMzDhZ5RqfmG2aX;u MYG8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOzV|MUmyNUc,OjN3M{G5NlE9N2F-
SY5Y NXzWc29FTnWwY4Tpc44hSXO|YYm= NFf5[oMxNjVxMT6wM|IvPS93IN88US=> MnGxNlQhcA>? MVnEUXNQ Mn;sbY5pcWKrdIOgZo91cCCnbnTv[4Vvd3W|IHPvcpN1cXS3dHn2[UBidmRiSVytOk1qdmS3Y3XkJHNVSVR|IHHjeIl3[XSrb36= MXe8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOzV|MUmyNUc,OjN3M{G5NlE9N2F-
Rh18 M{WyemZ2dmO2aX;uJGF{e2G7 NYTFXGVZOC53L{GuNE8zNjVxNTFOwG0> MmWyNlQhcA>? M1[5OWROW09? NXHadYROcW6qaXLpeJMh[m:2aDDlcoRw\2Wwb4XzJINwdnO2aYT1eIl3\SCjbnSgTWwuPi2rbnT1Z4VlKFOWQWSzJIFkfGm4YYTpc44> MVS8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOzV|MUmyNUc,OjN3M{G5NlE9N2F-
TC32 Ml\wSpVv[3Srb36gRZN{[Xl? NGXsdnUxNjVxMT6wM|IvPS93IN88US=> NWDWWJF2OjRiaB?= NX24VmMyTE2VTx?= NVXQbpNvcW6qaXLpeJMh[m:2aDDlcoRw\2Wwb4XzJINwdnO2aYT1eIl3\SCjbnSgTWwuPi2rbnT1Z4VlKFOWQWSzJIFkfGm4YYTpc44> NEDQS|c9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{M{WzNVkzOSd-MkO1N|E6OjF:L3G+
TPC-1 NVLS[mRDT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NGGyTWwyKML3TR?= M4\3NVAuPCCm NEXWOVFFVVOR M1PLcYlvcGmkaYTzJINmdGxiZ4Lve5RpKGGodHXyJFIh\CC2cnXheI1mdnR? NFzScZg9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{M{C1OlQ6QSd-MkOwOVY1QTl:L3G+
MZ-CRC1  M{flc2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NXLYPJQ6OSEEtV2= NF32WFUxNTViZB?= NXrpeopNTE2VTx?= M1fLNolvcGmkaYTzJINmdGxiZ4Lve5RpKGGodHXyJFEh\CC2cnXheI1mdnR? NFXaV5c9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{M{C1OlQ6QSd-MkOwOVY1QTl:L3G+
TT  MWjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? Mk\5NUDDvU1? NXSyfIlbOC12IHS= NYrifFljTE2VTx?= MYDpcohq[mm2czDj[YxtKGe{b4f0bEBi\nSncjCxJIQhfHKnYYTt[Y51 NVHsdpViRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkOwOVY1QTlpPkKzNFU3PDl7PD;hQi=>
TPC-1 NGDC[npHfW6ldHnvckBCe3OjeR?= MV[xJOK2VQ>? M{e1T|czKGh? NWfjN|JvTE2VTx?= MkLVbY5lfWOnczDHNUBjdG:la3Hn[S=> Mn;xQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjNyNU[0PVkoRjJ|MEW2OFk6RC:jPh?=
MZ-CRC1  MV7GeY5kfGmxbjDBd5NigQ>? NXfvbnRLOSEEtV2= MoTuO|IhcA>? MljCSG1UVw>? MnrBbY5lfWOnczDHNUBjdG:la3Hn[S=> MmTQQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjNyNU[0PVkoRjJ|MEW2OFk6RC:jPh?=
TT  M3jRSWZ2dmO2aX;uJGF{e2G7 NEiye40yKML3TR?= NYPjSJMyPzJiaB?= MXjEUXNQ NUTHTWpDcW6mdXPld{BIOSCkbH;jb4Fo\Q>? NHfPVYU9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{M{C1OlQ6QSd-MkOwOVY1QTl:L3G+
MZ-CRC1  NILQdFlCeG:ydH;zbZMhSXO|YYm= MkTYNUDDvU1? MUO0PEBp MlP5SG1UVw>? M1:4d4lv\HWlZYOgZZBweHSxc3nz M2fvTFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ|MEW2OFk6Lz5{M{C1OlQ6QTxxYU6=
TT  NWCzdoY3SXCxcITvd4l{KEG|c3H5 M2jsO|EhyrWP MoLYOFghcA>? M1HINWROW09? NUT0bZBDcW6mdXPld{BieG:ydH;zbZM> NVjTNpI1RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkOwOVY1QTlpPkKzNFU3PDl7PD;hQi=>
HD-LM2 NWDvUolvT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MX63NwKBkWh? NGC0OXJFVVOR NHSxNolKSzVyPUeuPFQ1KM7:TR?= M4HyNlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ{OEK5NFk1Lz5{MkiyPVA6PDxxYU6=
L-428 MWPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MV:3NwKBkWh? MXzEUXNQ NYXzbIpXUUN3ME23Mlk1PyEQvF2= NEnHTpQ9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MkiyPVA6PCd-MkK4NlkxQTR:L3G+
KM-H2 NGfE[2pIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MYG3NwKBkWh? NXXmbHB6TE2VTx?= MkTlTWM2OD1zLkOwPEDPxE1? NGPEUZA9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MkiyPVA6PCd-MkK4NlkxQTR:L3G+
L-540 MUfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MWW3NwKBkWh? MX;EUXNQ NEDQeFNKSzVyPUiuNlE3KM7:TR?= NG\ubnQ9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MkiyPVA6PCd-MkK4NlkxQTR:L3G+
HD-LM2 MULGeY5kfGmxbjDBd5NigQ>? MWqwMlEwOC53L{GvOUDPxE1? MXS3NwKBkWh? NHzHV3JFVVOR MkfkbY5pcWKrdIOgV3RCXDNuIGPURXQ2KGGwZDDTWGFVPiCyaH;zdIhwenmuYYTpc44> MUO8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOjh{OUC5OEc,OjJ6MkmwPVQ9N2F-
L-428 NHP3VmdHfW6ldHnvckBCe3OjeR?= M3PlPFAvOS9yLkWvNU82KM7:TR?= MnvrO|LjiImq NYW1VIJETE2VTx?= M{nUOolvcGmkaYTzJHNVSVR|LDDTWGFVPSCjbnSgV3RCXDZicHjvd5Bpd3K7bHH0bY9v NE[5ZlE9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MkiyPVA6PCd-MkK4NlkxQTR:L3G+
KM-H2 MV\GeY5kfGmxbjDBd5NigQ>? NWH4PYc3OC5zL{CuOU8yNzVizszN NEfTfJM4OuLCiXi= MX\EUXNQ Mnu0bY5pcWKrdIOgV3RCXDNuIGPURXQ2KGGwZDDTWGFVPiCyaH;zdIhwenmuYYTpc44> M2fvUVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ{OEK5NFk1Lz5{MkiyPVA6PDxxYU6=
L-540 MYPGeY5kfGmxbjDBd5NigQ>? MkTjNE4yNzBwNT:xM|Uh|ryP NEjVN484OuLCiXi= M3XPSWROW09? NUPYfZBvcW6qaXLpeJMhW1SDVEOsJHNVSVR3IHHu[EBUXEGWNjDwbI9{eGixconsZZRqd25? MYm8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOjh{OUC5OEc,OjJ6MkmwPVQ9N2F-
HD-LM2 NHLRXoRCeG:ydH;zbZMhSXO|YYm= MUexM|Uh|ryP M1rMRVcz6oDLaB?= MkTpSG1UVw>? NYX3XlFtcW6mdXPld{BieG:ydH;zbZM> M2XWUFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ{OEK5NFk1Lz5{MkiyPVA6PDxxYU6=
L-428 NWrHXFdpSXCxcITvd4l{KEG|c3H5 MnHQNU82KM7:TR?= M3vvUFcz6oDLaB?= MlX1SG1UVw>? NUjBTVZWcW6mdXPld{BieG:ydH;zbZM> M3LhPVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ{OEK5NFk1Lz5{MkiyPVA6PDxxYU6=
KM-H2 MnLlRZBweHSxc3nzJGF{e2G7 MnzNNU82KM7:TR?= NWHjcHZvPzMkgJno MVzEUXNQ M2jtbolv\HWlZYOgZZBweHSxc3nz MWW8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOjh{OUC5OEc,OjJ6MkmwPVQ9N2F-
L-540 NUP0NI1GSXCxcITvd4l{KEG|c3H5 MljaNU82KM7:TR?= NUnjSGF4PzMkgJno Mn25SG1UVw>? NHvPR4RqdmS3Y3XzJIFxd3C2b4Ppdy=> MoDxQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjJ6MkmwPVQoRjJ{OEK5NFk1RC:jPh?=
U251-MG NV6zZ3BxTnWwY4Tpc44hSXO|YYm= MWKxJOK2VQ>? NX21V|FYOC1zNjDo NIHlXoFqdmirYnn0d{Bkd26|dHn0eZRqfmViU2TBWE0{KGGwZDDKRWszKGGldHn2ZZRqd25? MXu8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOjB{N{[5NUc,OjJyMke2PVE9N2F-
U87-MG NVm5SWNiTnWwY4Tpc44hSXO|YYm= MWqxJOK2VQ>? M{\uXlAuOTZiaB?= MXvpcohq[mm2czDjc45{fGm2dYTpeoUhW1SDVD2zJIFv\CCMQVuyJIFkfGm4YYTpc44> MnfkQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjJyMke2PVEoRjJ{MEK3OlkyRC:jPh?=
4C8 MVXGeY5kfGmxbjDBd5NigQ>? M3XSd|EhyrWP NVzxS2ZMOC1zNjDo NV\OOVZJcW6qaXLpeJMh[2:wc4TpeJV1cX[nIGPURXQuOyCjbnSgTmFMOiCjY4TpeoF1cW:w NXXKTWFXRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkKwNlc3QTFpPkKyNFI4PjlzPD;hQi=>
U251-MG MV7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M1:xXVEwOTBiwsXN MkLhNlQwPDhxN{KgbC=> MXnpcohq[mm2czDj[YxtKHC{b3zp[oVz[XSrb36gZZQh[SClb37j[Y51emG2aX;uJI9nKDFyINM1US=> M1PuW|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ{MEK3OlkyLz5{MkCyO|Y6OTxxYU6=
U87-MG NGjxfmxIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NHX5VVEyNzFyINM1US=> NYC3N3pbOjRxNEivO|IhcA>? NHPveJhqdmirYnn0d{Bk\WyuIIDyc4xq\mW{YYTpc44h[XRiYTDjc45k\W62cnH0bY9vKG:oIEGwJOK2VQ>? MkLYQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjJyMke2PVEoRjJ{MEK3OlkyRC:jPh?=
4C8 NGTmSHFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MY[xM|ExKML3TR?= NVjNdJNiOjRxNEivO|IhcA>? M{[zc4lvcGmkaYTzJINmdGxicILvcIln\XKjdHnvckBifCCjIHPvcoNmdnS{YYTpc44hd2ZiMUCgxtVO M1XyelxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ{MEK3OlkyLz5{MkCyO|Y6OTxxYU6=
U266 NGjKR5NCeG:ydH;zbZMhSXO|YYm= M{XLbFAvPS1{IN88US=> MmLNOFgwPzJiaB?= MljNbY5lfWOnczDhdI9xfG:|aYOg[I9{\SCmZYDlcoRmdnSueR?= NYD6dGp1RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkGxOlQ2OTdpPkKxNVY1PTF5PD;hQi=>
Kms.11 MUDBdI9xfG:|aYOgRZN{[Xl? NV\rRXdYOC53LUKg{txO NH[2Vos1QC95MjDo NFnFXnpqdmS3Y3XzJIFxd3C2b4Ppd{Bld3OnIHTldIVv\GWwdHz5 NYjydmViRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkGxOlQ2OTdpPkKxNVY1PTF5PD;hQi=>
8226 MWnBdI9xfG:|aYOgRZN{[Xl? MW[wMlUuOiEQvF2= Mm\mOFgwPzJiaB?= M3Sx[Ylv\HWlZYOgZZBweHSxc3nzJIRwe2ViZHXw[Y5l\W62bIm= NHTG[GY9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MUG2OFUyPyd-MkGxOlQ2OTd:L3G+
SET2 M3PJb2dzd3e2aDDpcohq[mm2aX;uJIF{e2G7 MYS0PEBpenN? M1TuXWdzd3e2aDDpcohq[mm2aX;uJI9nKGi3bXHuJHNGXDJiY3XscJMh\XiycnXzd4lv\yCMYXuyJHY3OTeIIH31eIFvfCCjZoTldkA1QCCqcoOgZpkhVVSVIHHzd4F6NCCJSUWwJF0hOC5yMU[g{txONg>? MkPqQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjFzM{iyOFYoRjJzMUO4NlQ3RC:jPh?=
SET2 MmXUSpVv[3Srb36gZZN{[Xl? NVvlOJpROSCqch?= MlrqTY5pcWKrdHnvckBw\iCVdHH0N{BxcG:|cHjvdplt[XSrb36gbY4hcHWvYX6gV2VVOiClZXzsd{Bi\nSncjCxJIhzKGK7IGfld5Rmem5iYnzveJRqdmduIFnDOVAhRSByLkCyN{DPxE1w M{fkTlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJzMUO4NlQ3Lz5{MUGzPFI1PjxxYU6=
SET2 NWLUVFlDTnWwY4Tpc44h[XO|YYm= MlvBNUBpeg>? Ml7yTY5pcWKrdHnvckBw\iCVdHH0OUBxcG:|cHjvdplt[XSrb36gbY4hcHWvYX6gV2VVOiClZXzsd{Bi\nSncjCxJIhzKGK7IGfld5Rmem5iYnzveJRqdmduIFnDOVAhRSByLkCyOUDPxE1w NHT4TJo9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MUGzPFI1Pid-MkGxN|gzPDZ:L3G+
HEL NHrhfJFHfW6ldHnvckBie3OjeR?= M3;BTVEhcHJ? MUXJcohq[mm2aX;uJI9nKFO2YYS1JJBpd3OyaH;yfYxifGmxbjDpckBpfW2jbjDISWwh[2WubIOgZYZ1\XJiMTDodkBjgSCZZYP0[ZJvKGKub4T0bY5oNCCLQ{WwJF0hOC5yNEGg{txONg>? M4fCWVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJzMUO4NlQ3Lz5{MUGzPFI1PjxxYU6=
Ba/F3 M{DsTGZ2dmO2aX;uJIF{e2G7 NVrrV3R{UW6qaXLpeIlwdiCxZjDTeIF1PSCyaH;zdIhwenmuYYTpc44hcW5ibX;1d4UhSmFxRkOgZ4VtdHNiZYjwdoV{e2mwZzDUSWwuUmGtMjygTWM2OCB;IECuNFQ3KM7:TT6= M{DkOFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJzMUO4NlQ3Lz5{MUGzPFI1PjxxYU6=
UKE1 M2POVmdzd3e2aDDpcohq[mm2aX;uJIF{e2G7 NEHwSVY1QCCqcoO= Mo\rS5Jwf3SqIHnubIljcXSrb36gc4YhcHWvYX6gWWtGOSClZXzsd{BmgHC{ZYPzbY5oKEqja{KgWlYyP0ZibYX0ZY51KGGodHXyJFQ5KGi{czDifUBOXFNiYYPzZZktKEeLNUCgQUAxNjB3NDFOwG0v Ml7rQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjFzM{iyOFYoRjJzMUO4NlQ3RC:jPh?=
BA/F3 MUjHdo94fGhiaX7obYJqfGmxbjDhd5NigQ>? MoPmOFghcHK| M1TJO2dzd3e2aDDpcohq[mm2aX;uJI9nKG2xdYPlJGJCN0Z|IHPlcIx{KGW6cILld5NqdmdiVHXsMWpCUzJia3nuZZNmKGGodHXyJFQ5KGi{czDifUBOXFNiYYPzZZktKEeLNUCgQUAxNjB4IN88UU4> NXfOfJFsRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkGxN|gzPDZpPkKxNVM5OjR4PD;hQi=>
HEL MkXvSpVv[3Srb36gZZN{[Xl? M3HDXFEhcHJ? MmS3TY5pcWKrdHnvckBw\iCVdHH0N{BxcG:|cHjvdplt[XSrb36gbY4hcHWvYX6gTGVNKGOnbHzzJIFnfGW{IEGgbJIh[nliV3XzeIVzdiCkbH;0eIlv\yxiSVO1NEA:KDBwMEig{txONg>? NYfjOmR2RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkGxN|gzPDZpPkKxNVM5OjR4PD;hQi=>
HEL MoqxS5Jwf3SqIHnubIljcXSrb36gZZN{[Xl? MVm0PEBpenN? MWLHdo94fGhiaX7obYJqfGmxbjDv[kBpfW2jbjDISWwh[2WubIOg[ZhxemW|c3nu[{BL[Wt{IG[2NVdHKG23dHHueEBi\nSncjC0PEBpenNiYomgUXRUKGG|c3H5MEBIUTVyIE2gNE4{QSEQvF2u M2PUbFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJzMUO4NlQ3Lz5{MUGzPFI1PjxxYU6=
BA/F3 MVTHdo94fGhiaX7obYJqfGmxbjDhd5NigQ>? NHziTGo1QCCqcoO= NXjHNZFwT3Kxd4ToJIlvcGmkaYTpc44hd2ZibX;1d4UhSkFxRkOgZ4VtdHNiZYjwdoV{e2mwZzDU[YwuUkGNMTDrbY5ie2ViYX\0[ZIhPDhiaILzJIJ6KE2WUzDhd5NigSxiR1m1NEA:KDBwNzFOwG0v M1\LVlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJzMUO4NlQ3Lz5{MUGzPFI1PjxxYU6=
BA/F3 MoDjS5Jwf3SqIHnubIljcXSrb36gZZN{[Xl? NIjDUVQ1QCCqcoO= NFnuUFVIem:5dHigbY5pcWKrdHnvckBw\iCvb4Xz[UBDSS:IMzDj[YxteyCneIDy[ZN{cW6pIGTlcE1VgWt{IHvpcoF{\SCjZoTldkA1QCCqcoOgZpkhVVSVIHHzd4F6NCCJSUWwJF0hOiEQvF2u M1vE[lxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJzMUO4NlQ3Lz5{MUGzPFI1PjxxYU6=
BA/F3 NXjQdXR1T3Kxd4ToJIlvcGmkaYTpc44h[XO|YYm= NXHEXIlkPDhiaILz M2eycGdzd3e2aDDpcohq[mm2aX;uJI9nKG2xdYPlJGJCN0Z|IHPlcIx{KGW6cILld5NqdmdiVHXsMWpCUzNia3nuZZNmKGGodHXyJFQ5KGi{czDifUBOXFNiYYPzZZktKEeLNUCgQUAzNjFizszNMi=> MXu8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOTF|OEK0Okc,OjFzM{iyOFY9N2F-
UKE1 MlnLSpVv[3Srb36gZZN{[Xl? NVXzcm5mOSCqch?= M13hVGlvcGmkaYTpc44hd2ZiU4TheFUheGixc4Doc5J6dGG2aX;uJIlvKGi3bXHuJHVMTTFiY3XscJMh[W[2ZYKgNUBpeiCkeTDX[ZN1\XKwIHLsc5R1cW6p MY[8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOTF|OEK0Okc,OjFzM{iyOFY9N2F-
SW620 M3H3SmNmdGxiY4njcIUh[XO|YYm= MoXsN{4{KHWP M2W2bVI1KGi{cx?= MoLYR4VtdCCleXPs[UBienKnc4SgbY4hcHWvYX6gV3c3OjBiY3XscJMh[XO|ZYPz[YQh[XNiYXPjeY12dGG2aX;uJIF1KEd{L12gdIhie2ViYYSgN{4{KHWPIHHmeIVzKDJ2IHjyd{BjgSCobH;3JIN6fG:vZYTyfS=> NXvre2liRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkGxN|gzPDZpPkKxNVM5OjR4PD;hQi=>
HEL MlnBSpVv[3Srb36gZZN{[Xl? M2LR[FAvOyC3TR?= M1:xVlUhdWmwcx?= Mme0TY5pcWKrdHnvckBw\iCVdHH0OUBxcG:|cHjvdplt[XSrb36gbY4hcHWvYX6gTGVNKGOnbHzzJIF1KDBwMzD1UUBi\nSncjC1JI1qdnNiYomgW4V{fGW{bjDicI91fGmwZx?= M2Thb|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJzMUO4NlQ3Lz5{MUGzPFI1PjxxYU6=
HEL MoPTSpVv[3Srb36gZZN{[Xl? NH:3fG4xNjNidV2= M1vVdVMxKHSxIE[wJI1qdnN? M13ubWlvcGmkaYTpc44hd2ZiU4TheFUheGixc4Doc5J6dGG2aX;uJIlvKGi3bXHuJGhGVCClZXzsd{BifCByLkOgeW0h[W[2ZYKgN|AhfG9iNkCgcYlveyCkeTDX[ZN1\XKwIHLsc5R1cW6p MWK8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOTF|OEK0Okc,OjFzM{iyOFY9N2F-
BA/F3 NFXaTWpCdnSrdIXtc5Ih[XO|YYm= NX7TZXd4OzBibXevb4c> MV[xNkBpenN? MljNRY51cXS3bX;yJIFkfGm4aYT5JIFo[Wmwc4SgcY92e2ViQlGvSlMh[2WubIOg[ZhxemW|c3nu[{BV\WxvSlHLNkB5\W6xZ4Lh[pRm\CCrbjDOR5IhdW:3c3WgZZN{\XO|ZXSgZZMhemWmdXP0bY9vKG:oIIDoc5NxcG:{eXzheIVlKFO2YYS1JIxmfmWuIHnuJJNxdGWnbjDheEA{OCCvZz;r[{wheG9iYX\0[ZIhOTJiaILzJIJ6KFenc4Tldo4h[myxdITpcoc> MYK8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOTF|OEK0Okc,OjFzM{iyOFY9N2F-
HEL MYjGeY5kfGmxbjDhd5NigQ>? NUHjfGYxOC5|IIXN MVS1JI1qdnN? NELaWFRKdmirYnn0bY9vKG:oIGP0ZZQ{KHCqb4PwbI9zgWyjdHnvckBqdiCqdX3hckBJTUxiY3XscJMh[XRiMD6zJJVOKGGodHXyJFUhdWmwczDifUBY\XO2ZYLuJIJtd3S2aX7n M1;z[VxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJzMUO4NlQ3Lz5{MUGzPFI1PjxxYU6=
HEL NEeybYlHfW6ldHnvckBie3OjeR?= MnOwNE4{KHWP NYewUVRVOzBidH:gOlAhdWmwcx?= MkDSTY5pcWKrdHnvckBw\iCVdHH0N{BxcG:|cHjvdplt[XSrb36gbY4hcHWvYX6gTGVNKGOnbHzzJIF1KDBwMzD1UUBi\nSncjCzNEB1dyB4MDDtbY5{KGK7IGfld5Rmem5iYnzveJRqdmd? M1rFS|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJzMUO4NlQ3Lz5{MUGzPFI1PjxxYU6=
Hs578T MnjzSpVv[3Srb36gZZN{[Xl? MVmxJJVO NVXNV49COjRiaILz M2DUOGlvcGmkaYTpc44hd2ZiU2TBWFNENW2nZHnheIVlKHS{YX7zZ5JqeHSrb36gbY4hcHWvYX6gTJM2PziWIHPlcIx{KGG2IEGgeW0h[W[2ZYKgNlQhcHK|IHL5JIx2[2moZYLhd4UhemWyb4L0[ZIh\2WwZTDhd5NigQ>? NGK5e4E9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NEm3PFEyOid-MkS5O|gyOTJ:L3G+
NCI-H1975 M2LZWmZ2dmO2aX;uJIF{e2G7 MmrwNE4xODNidH:gN{B2VQ>? NXvVfJFlOiCqcoO= MknuTY5pcWKrdHnvckBw\iCMQVuxJIlvKGi3bXHuJG5EUS2KMUm3OUBk\WyuczDhd5Nme3OnZDDhd{Bz\WS3Y4Tpc44hcW5iU2TBWFMheGixc4Doc5J6dGG2aX;uJIF1KDBwMECzJJRwKDNidV2gZYZ1\XJiMjDodpMh[nliV3XzeIVzdiCkbH;0JIFv[Wy7c3nz MoTyQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjZ4MUS0NFgoRjJ4NkG0OFA5RC:jPh?=
HEL 92.1.7 MXnGeY5kfGmxbjDhd5NigQ>? M{LtZ|IhcHK| M4fS[GlvcGmkaYTpc44hd2ZiSlHLNkBqdiCqdX3hckBJTUxiOUKuNU44KGOnbHzzJIF{e2W|c3XkJIF{KHKnZIXjeIlwdiCrbjDTWGFVPSCyaH;zdIhwenmuYYTpc44h[W[2ZYKgNkBpenNiYomgW4V{fGW{bjDicI91KGGwYXz5d4l{ MmTvQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjZ4MUS0NFgoRjJ4NkG0OFA5RC:jPh?=
DAOY NFXlOXFyUFSVIHHzd4F6 MYnxTHRUKG:oIIDl[IlifHKrYzDjZY5k\XJiY3XscEBtcW6nczD0c{Bq\GWwdHnmfUBufWy2aYDs[UBweHCxcoT1col1cWW|IH\vdkBlenWpIILldJVzeG:|aX7nPkBRemmvYYL5JJNkemWnbjDmc5IhTEGRWTDj[Yxtew>? NXm1[oJjRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkm0N|UyOzlpPkK5OFM2OTN7PD;hQi=>
SJ-GBM2 M3vxdJFJXFNiYYPzZZk> M2Hrb5FJXFNib3[gdIVlcWG2cnnjJINidmOncjDj[YxtKGyrbnXzJJRwKGmmZX70bYZ6KG23bITpdIxmKG:ycH;yeJVvcXSrZYOg[o9zKGS{dXegdoVxfXKyb4Ppcoc7KFC{aX3hdpkhe2O{ZXXuJIZweiCVSj3HRm0zKGOnbHzz MXe8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQTR|NUGzPUc,Ojl2M{WxN|k9N2F-
A673 NGrTRodyUFSVIHHzd4F6 MVjxTHRUKG:oIIDl[IlifHKrYzDjZY5k\XJiY3XscEBtcW6nczD0c{Bq\GWwdHnmfUBufWy2aYDs[UBweHCxcoT1col1cWW|IH\vdkBlenWpIILldJVzeG:|aX7nPkBRemmvYYL5JJNkemWnbjDmc5IhSTZ5MzDj[Yxtew>? MkPtQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjl2M{WxN|koRjJ7NEO1NVM6RC:jPh?=
SK-N-MC NUDvcII4eUiWUzDhd5NigQ>? M3TGUpFJXFNib3[gdIVlcWG2cnnjJINidmOncjDj[YxtKGyrbnXzJJRwKGmmZX70bYZ6KG23bITpdIxmKG:ycH;yeJVvcXSrZYOg[o9zKGS{dXegdoVxfXKyb4Ppcoc7KFC{aX3hdpkhe2O{ZXXuJIZweiCVSz3OMW1EKGOnbHzz MVK8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQTR|NUGzPUc,Ojl2M{WxN|k9N2F-
BT-37 MlHMdWhVWyCjc4PhfS=> NUTSVGxDeUiWUzDv[kBx\WSrYYTybYMh[2GwY3XyJINmdGxibHnu[ZMhfG9iaXTlcpRq\nlibYXseIlxdGVib4Dwc5J1fW6rdHnld{Bnd3JiZIL1[{Bz\XC3coDvd4lv\zpiUILpcYFzgSC|Y4Ll[Y4h\m:{IFLUMVM4KGOnbHzz Mmr3QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjl2M{WxN|koRjJ7NEO1NVM6RC:jPh?=
NB-EBc1 MkTudWhVWyCjc4PhfS=> NFW3VHNyUFSVIH;mJJBm\GmjdILpZ{Bk[W6lZYKgZ4VtdCCuaX7ld{B1dyCrZHXueIlngSCvdXz0bZBt\SCxcIDvdpR2dmm2aXXzJIZweiCmcoXnJJJmeHW{cH;zbY5oQiCScnntZZJ6KHOlcnXlckBnd3JiTlKtSWJkOSClZXzsdy=> MVm8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQTR|NUGzPUc,Ojl2M{WxN|k9N2F-
Saos-2 NWXkVWgxeUiWUzDhd5NigQ>? MofYdWhVWyCxZjDw[YRq[XS{aXOgZ4Fv[2W{IHPlcIwhdGmwZYOgeI8hcWSnboTp[pkhdXWudHnwcIUhd3Cyb4L0eY5qfGmnczDmc5Ih\HK3ZzDy[ZB2enCxc3nu[|ohWHKrbXHyfUB{[3KnZX6g[o9zKFOjb4OtNkBk\Wyucx?= MonSQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjl2M{WxN|koRjJ7NEO1NVM6RC:jPh?=
SK-N-SH NVvBdGJZeUiWUzDhd5NigQ>? NIW4dFRyUFSVIH;mJJBm\GmjdILpZ{Bk[W6lZYKgZ4VtdCCuaX7ld{B1dyCrZHXueIlngSCvdXz0bZBt\SCxcIDvdpR2dmm2aXXzJIZweiCmcoXnJJJmeHW{cH;zbY5oQiCScnntZZJ6KHOlcnXlckBnd3JiU1utUk1UUCClZXzsdy=> NVe3e4JPRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkm0N|UyOzlpPkK5OFM2OTN7PD;hQi=>
NB1643 NGXu[plyUFSVIHHzd4F6 MlnQdWhVWyCxZjDw[YRq[XS{aXOgZ4Fv[2W{IHPlcIwhdGmwZYOgeI8hcWSnboTp[pkhdXWudHnwcIUhd3Cyb4L0eY5qfGmnczDmc5Ih\HK3ZzDy[ZB2enCxc3nu[|ohWHKrbXHyfUB{[3KnZX6g[o9zKE6EMU[0N{Bk\Wyucx?= NW\sTVZKRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkm0N|UyOzlpPkK5OFM2OTN7PD;hQi=>
BT-12 NVS1c|I2eUiWUzDhd5NigQ>? MYPxTHRUKG:oIIDl[IlifHKrYzDjZY5k\XJiY3XscEBtcW6nczD0c{Bq\GWwdHnmfUBufWy2aYDs[UBweHCxcoT1col1cWW|IH\vdkBlenWpIILldJVzeG:|aX7nPkBRemmvYYL5JJNkemWnbjDmc5IhSlRvMUKgZ4VtdHN? NXzOXGJ1RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkm0N|UyOzlpPkK5OFM2OTN7PD;hQi=>
OHS-50 MXHxTHRUKGG|c3H5 MWXxTHRUKG:oIIDl[IlifHKrYzDjZY5k\XJiY3XscEBtcW6nczD0c{Bq\GWwdHnmfUBufWy2aYDs[UBweHCxcoT1col1cWW|IH\vdkBlenWpIILldJVzeG:|aX7nPkBRemmvYYL5JJNkemWnbjDmc5IhV0iVLUWwJINmdGy| MYq8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQTR|NUGzPUc,Ojl2M{WxN|k9N2F-
RD M4rnSJFJXFNiYYPzZZk> NX\IV3lleUiWUzDv[kBx\WSrYYTybYMh[2GwY3XyJINmdGxibHnu[ZMhfG9iaXTlcpRq\nlibYXseIlxdGVib4Dwc5J1fW6rdHnld{Bnd3JiZIL1[{Bz\XC3coDvd4lv\zpiUILpcYFzgSC|Y4Ll[Y4h\m:{IGLEJINmdGy| NE\GTmM9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OUSzOVE{QSd-Mkm0N|UyOzl:L3G+
MG 63 (6-TG R) MU\xTHRUKGG|c3H5 MVzxTHRUKG:oIIDl[IlifHKrYzDjZY5k\XJiY3XscEBtcW6nczD0c{Bq\GWwdHnmfUBufWy2aYDs[UBweHCxcoT1col1cWW|IH\vdkBlenWpIILldJVzeG:|aX7nPkBRemmvYYL5JJNkemWnbjDmc5IhVUdiNkOgLFYuXEdiUjmgZ4VtdHN? NWHUPG1FRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkm0N|UyOzlpPkK5OFM2OTN7PD;hQi=>
Rh41 MX\xTHRUKGG|c3H5 M4TQTpFJXFNib3[gdIVlcWG2cnnjJINidmOncjDj[YxtKGyrbnXzJJRwKGmmZX70bYZ6KG23bITpdIxmKG:ycH;yeJVvcXSrZYOg[o9zKGS{dXegdoVxfXKyb4Ppcoc7KFC{aX3hdpkhe2O{ZXXuJIZweiCUaESxJINmdGy| M{W3PVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ7NEO1NVM6Lz5{OUSzOVE{QTxxYU6=

... Click to View More Cell Line Experimental Data

Assay
Methods Test Index PMID
Western blot
p-STAT3 / STAT3 / p-JAK2 / JAK2 ; 

PubMed: 22027691     


Cells were treated with AZD1480 for the indicated times, lysed and immunoblotted with the indicated antibodies. 

p-STAT1 / STAT1 / p-STAT5 / STAT5 / p-STAT6 / STAT6 ; 

PubMed: 22829094     


Western blot assay of the four HL cell lines treated with increasing doses of AZD1480 (0.1–5 μM) for 72 h. 

p-ERK / ERK / p-p38 / p38 / SOCS3 / p-SHP2 / SHP2 ; 

PubMed: 22829094     


Representative western blot assay showing increased levels of ERK, p38 and SHP-2 phosphorylation in HD-LM2 and L-428, after treatment for 72 h with increasing doses of AZD1480 (0.1-5 μM). In contrast, L-540 showed a dose-dependent inhibition of ERK and p38 activation without increased SHP-2 phosphorylation. SOCS-3 levels decreased in all the cell lines.

22027691 22829094
Immunofluorescence
pSTAT5; 

PubMed: 30140255     


HepG2 cells were incubated in the presence of Pro-Gly (0.5 mM) and/or AZD1480 (1 μM) for 6 h and phospho-STAT5 translocation to nuclei was detected by ICC. Scale bar, 10 μm. The IP and ICC experiments were conducted independently for 3 times, with 3 replicates each time.

30140255
Growth inhibition assay
Cell proliferation ; 

PubMed: 22027691     


Cells were treated with AZD1480 for the indicated times, and the WST-1 cell proliferation assay performed. The 48 and 72 h time points were statistically significant. Data represent mean ± SD, replicates of three (**, p<0.001; ANOVA). 

Cell viability; 

PubMed: 25855603     


IL-3-independent Ba/F3 cells were treated with increasing concentrations of the JAK inhibitor AZD1480 showing submicromolar inhibition of proliferation.

22027691 25855603
In vivo AZD1480 inhibits the STAT3 phosphorylation in an xenograft model of human solid tumors and multiple myeloma. [1] In vivo, AZD1480 inhibits the growth of subcutaneous tumors and increases survival of mice bearing intracranial glioblastoma (GBM) tumors by inhibiting STAT-3 activity, indicating that pharmacologic inhibition of the JAK/STAT-3 pathway by AZD1480 should be considered for study in the treatment of patients with GBM tumors. [3]AZD1480 blocks lung infiltration of myeloid cells and formation of pulmonary metastases in both mouse syngeneic experimental and spontaneous metastatic models. Furthermore, AZD1480 reduces angiogenesis and metastasis in a human xenograft tumor model. [4] The Jak2 inhibitor, AZD1480, suppresses the growth of human solid tumor xenografts harboring persistent Stat3 activity. [5]

Protocol

Kinase Assay:[5]
- Collapse

kinase assays:

Inhibition studies of AZD1480 are performed using recombinant Jak1, Jak2, or Jak3 under buffer conditions of 50 mM HEPES pH 7.3, 1 mM DTT, 0.01% Tween-20, 50 mM/ml BSA, and 10 mM MgCl2. Jak3 enzyme is expressed as N-terminal GST fusion in insect cells and purified by glutathione-affinity and size-exclusion chromatographies. Enzymes are assayed in the presence of AZD1480 (10 point dose response, in triplicate, from 8.3 μM to 0.3 nM in half-log dilution steps) using 1.5 μM peptide substrate (Jak1: FITC-C6-KKHTDDGYMPMSPGVA-NH2, Jak2 and Jak3: FAM-SRCtide) and screened under their respective ATP Km (Jak1: 55 μM, Jak2: 15 μM, Jak3: 3 μM) and approximated physiological ATP concentration of 5 mM. Phosphorylated and unphosphorylated peptides are separated and quantified by a Caliper LC3000 system for calculating percent inhibition.
Cell Research:[4]
- Collapse
  • Cell lines: Renca or 786-O cells, mouse endothelial cells and splenic CD11b+/c-myeloid cells, HUVECs
  • Concentrations: ~1 μM
  • Incubation Time: 48 or 24 hours
  • Method: Renca or 786-O cells are suspended in DMEM medium with 5% FBS , and seeded in 96-well plates (5×103 per well) to allow adhesion and then treated with DMSO or AZD1480 for 48 hours. Cell viability is determined by MTS assay. Absorbance at 490 nm is measured with Mikrotek Laborsysteme. Mouse endothelial cells and splenic CD11b+/c- myeloid cells are enriched from tumor-bearing mice,and cultured in 5% FBS RPMI-1640 medium. HUVECs are cultured on collagen 1–coated plates in complete medium. All cells are treated with DMSO and AZD1480 at various doses for 24 hours. Cell viability is determined by counting cell number manually. All the experiments are repeated 3 times.
    (Only for Reference)
Animal Research:[4]
- Collapse
  • Animal Models: Female BALB/c and athymic nude (NCR - nu/nu) mice (7–8 weeks old)
  • Dosages: Once a day at the dose of 50 mg/kg or twice daily at 30 mg/kg
  • Administration: Oral gavage
    (Only for Reference)

Solubility (25°C)

In vitro DMSO 69 mg/mL warmed (197.83 mM)
Water Insoluble
Ethanol Insoluble
In vivo Add solvents to the product individually and in order(Data is from Selleck tests instead of citations):
30% PEG400+0.5% Tween80+5% propylene glycol
For best results, use promptly after mixing.
5 mg/mL

* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.

Chemical Information

Molecular Weight 348.77
Formula

C14H14ClFN8

CAS No. 935666-88-9
Storage powder
in solvent
Synonyms N/A
Smiles CC1=CC(=NN1)NC2=NC(=NC=C2Cl)NC(C)C3=NC=C(C=N3)F

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Dosage mg/kg Average weight of animals g Dosing volume per animal ul Number of animals
Step 2: Enter the in vivo formulation ()
% DMSO % % Tween 80 % ddH2O
CalculateReset

Bio Calculators

Molarity Calculator

Molarity Calculator

Calculate the mass, volume or concentration required for a solution. The Selleck molarity calculator is based on the following equation:

Mass (mg) = Concentration (mM) × Volume (mL) × Molecular Weight (g/mol)

  • Mass
    Concentration
    Volume
    Molecular Weight

*When preparing stock solutions, please always use the batch-specific molecular weight of the product found on the via label and SDS / COA (available on product pages).

Dilution Calculator

Dilution Calculator

Calculate the dilution required to prepare a stock solution. The Selleck dilution calculator is based on the following equation:

Concentration (start) x Volume (start) = Concentration (final) x Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2 ( Input Output )

  • C1
    V1
    C2
    V2

* When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / COA (available online).

The Serial Dilution Calculator Equation

  • Serial Dilutions

  • Computed Result

  • C1=C0/X C1: LOG(C1):
    C2=C1/X C2: LOG(C2):
    C3=C2/X C3: LOG(C3):
    C4=C3/X C4: LOG(C4):
    C5=C4/X C5: LOG(C5):
    C6=C5/X C6: LOG(C6):
    C7=C6/X C7: LOG(C7):
    C8=C7/X C8: LOG(C8):
Molecular Weight Calculator

Molecular Weight Calculator

Enter the chemical formula of a compound to calculate its molar mass and elemental composition:

Total Molecular Weight: g/mol

Tip: Chemical formula is case sensitive. C10H16N2O2 c10h16n2o2

Instructions to calculate molar mass (molecular weight) of a chemical compound:

To calculate molar mass of a chemical compound, please enter its chemical formula and click 'Calculate'.

Definitions of molecular mass, molecular weight, molar mass and molar weight:

Molecular mass (molecular weight) is the mass of one molecule of a substance and is expressed in the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.

Molarity Calculator

Mass Concentration Volume Molecular Weight

Clinical Trial Information

NCT Number Recruitment interventions Conditions Sponsor/Collaborators Start Date Phases
NCT01219543 Terminated Drug: AZD1480 Daily|Drug: AZD1480 BID Solid Tumour|Advanced Solid Malignancies|Child-Pugh A to B7 Advanced Hepatocellular Carcinoma|EGFR and/or ROS Mutant NSCLC|Lung Metastasis Carcinoma|Gastric Cancer AstraZeneca November 2010 Phase 1
NCT01112397 Terminated Drug: AZD1480 Solid Malignancies AstraZeneca April 2010 Phase 1

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

  • * Indicates a Required Field

JAK Signaling Pathway Map

JAK Inhibitors with Unique Features

Related JAK Products

Tags: buy AZD1480|AZD1480 ic50|AZD1480 price|AZD1480 cost|AZD1480 solubility dmso|AZD1480 purchase|AZD1480 manufacturer|AZD1480 research buy|AZD1480 order|AZD1480 mouse|AZD1480 chemical structure|AZD1480 mw|AZD1480 molecular weight|AZD1480 datasheet|AZD1480 supplier|AZD1480 in vitro|AZD1480 cell line|AZD1480 concentration|AZD1480 nmr|AZD1480 in vivo|AZD1480 clinical trial|AZD1480 inhibitor|AZD1480 JAK/STAT inhibitor
×
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID